BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9614215)

  • 1. Pharmacological properties of the T-type Ca2+ current of mouse spermatogenic cells.
    Arnoult C; Villaz M; Florman HM
    Mol Pharmacol; 1998 Jun; 53(6):1104-11. PubMed ID: 9614215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
    Bezprozvanny I; Tsien RW
    Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.
    Aczél S; Kurka B; Hering S
    Br J Pharmacol; 1998 Oct; 125(3):447-54. PubMed ID: 9806326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical and pharmacological characterization of spermatogenic T-type calcium current in mice lacking the CaV3.1 (alpha1G) calcium channel: CaV3.2 (alpha1H) is the main functional calcium channel in wild-type spermatogenic cells.
    Stamboulian S; Kim D; Shin HS; Ronjat M; De Waard M; Arnoult C
    J Cell Physiol; 2004 Jul; 200(1):116-24. PubMed ID: 15137064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
    Gomora JC; Xu L; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular T-type calcium channels: physiological and pharmacological significance.
    Triggle DJ
    J Hypertens Suppl; 1997 Dec; 15(5):S9-15. PubMed ID: 9481611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells.
    Rossier MF; Ertel EA; Vallotton MB; Capponi AM
    J Pharmacol Exp Ther; 1998 Dec; 287(3):824-31. PubMed ID: 9864260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels.
    Mehrke G; Zong XG; Flockerzi V; Hofmann F
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1483-8. PubMed ID: 7996461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones.
    Viana F; Van den Bosch L; Missiaen L; Vandenberghe W; Droogmans G; Nilius B; Robberecht W
    Cell Calcium; 1997 Oct; 22(4):299-311. PubMed ID: 9481480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mibefradil, a blocker of T-type Ca2+ channels, in single myocytes and intact muscle of guinea-pig heart.
    Emanuel K; Mackiewicz U; Pytkowski B; Lewartowski B
    J Physiol Pharmacol; 1998 Dec; 49(4):577-90. PubMed ID: 10069698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
    Sarsero D; Fujiwara T; Molenaar P; Angus JA
    Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neoglycoprotein mannose-bovine serum albumin, but not progesterone, activates T-type calcium channels in human spermatozoa.
    Blackmore PF; Eisoldt S
    Mol Hum Reprod; 1999 Jun; 5(6):498-506. PubMed ID: 10340995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone-mediated calcium influx and acrosome reaction of human spermatozoa: pharmacological investigation of T-type calcium channels.
    Garcia MA; Meizel S
    Biol Reprod; 1999 Jan; 60(1):102-9. PubMed ID: 9858492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Ro 40-5967 and verapamil with the stably expressed alpha 1-subunit of the cardiac L-type calcium channel.
    Lacinová L; Welling A; Bosse E; Ruth P; Flockerzi V; Hofmann F
    J Pharmacol Exp Ther; 1995 Jul; 274(1):54-63. PubMed ID: 7616442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltage-dependent calcium channels.
    Lacinová L
    Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mibefradil (Ro 40-5967) inhibits several Ca2+ and K+ currents in human fusion-competent myoblasts.
    Liu JH; Bijlenga P; Occhiodoro T; Fischer-Lougheed J; Bader CR; Bernheim L
    Br J Pharmacol; 1999 Jan; 126(1):245-50. PubMed ID: 10051142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental downregulation of low-voltage-activated Ca2+ channels in Cajal-Retzius cells of the mouse visual cortex.
    Kirmse K; Grantyn R; Kirischuk S
    Eur J Neurosci; 2005 Jun; 21(12):3269-76. PubMed ID: 16026465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mibefradil, A T-type calcium channel antagonist in Y1 cells.
    Esneu M; Gallo-Payet N; Payet MD
    Endocr Res; 1998; 24(3-4):449-54. PubMed ID: 9888524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mibefradil, a selective T-type Ca2+ channel antagonist, on sino-atrial node and ventricular myocardia.
    Masumiya H; Kase J; Tanaka Y; Tanaka H; Shigenobu K
    Res Commun Mol Pathol Pharmacol; 1999; 104(3):321-9. PubMed ID: 10741382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
    Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
    Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.